Alliance-A042302: Phase III Evaluation of Fixed Duration Zanubrutinib Plus Sonrotoclax-Based Therapy Compared to Continuous Zanubrutinib in Previously Untreated Older Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Objective

The Alliance for Clinical Trials in Oncology is a research organization that focuses on developing and conducting clinical trials to improve cancer treatment and patient outcomes. It is part of the National Cancer Institute's cooperative groups, integrating expertise in various oncology disciplines. It collaborates with the National Cancer Institute's Community Oncology Research Program (NCORP) to bring these trials to community settings, improving access to advanced cancer care.

National Clinical Trial (NCT) Number: 07321652

National Library of Medicine clinicaltrials.gov Website Address: https://clinicaltrials.gov/study/NCT07321652

Location: Essentia Health Cancer Centers


Research Study Categories

Specialties

  • Hematology

Contact

Cancer Clinical Trials at 218-786-3308 or 844-681-7944, [email protected]

X

Like most websites, we use cookies and other technologies to keep our website reliable, secure, and to better understand how our site is used. By using our site, you agree to our use of these tools. See website policy